Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action

被引:183
作者
Mlost, Jakub [1 ]
Bryk, Marta [1 ]
Starowicz, Katarzyna [1 ]
机构
[1] Polish Acad Sci, Maj Inst Pharmacol, Dept Neurochem, PL-31343 Krakow, Poland
关键词
CBD; network pharmacology; pain; neuropathic; osteoarthritis; BLOOD MONONUCLEAR-CELLS; DOUBLE-BLIND; NEUROPATHIC PAIN; CANNABINOID RECEPTOR; MULTIPLE-SCLEROSIS; CONSTITUENT CANNABIDIOL; MOLECULAR TARGETS; OROMUCOSAL SPRAY; CANCER-PATIENTS; MOUSE MODEL;
D O I
10.3390/ijms21228870
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cannabis has a long history of medical use. Although there are many cannabinoids present in cannabis, Delta 9tetrahydrocannabinol (Delta 9-THC) and cannabidiol (CBD) are the two components found in the highest concentrations. CBD itself does not produce typical behavioral cannabimimetic effects and was thought not to be responsible for psychotropic effects of cannabis. Numerous anecdotal findings testify to the therapeutic effects of CBD, which in some cases were further supported by research findings. However, data regarding CBD's mechanism of action and therapeutic potential are abundant and omnifarious. Therefore, we review the basic research regarding molecular mechanism of CBD's action with particular focus on its analgesic potential. Moreover, this article describes the detailed analgesic and anti-inflammatory effects of CBD in various models, including neuropathic pain, inflammatory pain, osteoarthritis and others. The dose and route of the administration-dependent effect of CBD, on the reduction in pain, hyperalgesia or allodynia, as well as the production of pro and anti-inflammatory cytokines, were described depending on the disease model. The clinical applications of CBD-containing drugs are also mentioned. The data presented herein unravel what is known about CBD's pharmacodynamics and analgesic effects to provide the reader with current state-of-art knowledge regarding CBD's action and future perspectives for research.
引用
收藏
页码:1 / 22
页数:21
相关论文
共 126 条
[1]   Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain [J].
Abraham, Antony D. ;
Leung, Edward J. Y. ;
Wong, Brenden A. ;
Rivera, Zeena M. G. ;
Kruse, Lauren C. ;
Clark, Jeremy J. ;
Land, Benjamin B. .
NEUROPSYCHOPHARMACOLOGY, 2020, 45 (07) :1105-1114
[2]   Structure of cannabidiol, a product isolated from the marihuana extract of Minnesota wild hemp I [J].
Adams, R ;
Hunt, M ;
Clark, JH .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1940, 62 :196-200
[3]   The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function [J].
Ahrens, Joerg ;
Demir, Reyhan ;
Leuwer, Martin ;
de la Roche, Jeanne ;
Krampfl, Klaus ;
Foadi, Nilufar ;
Karst, Matthias ;
Haeseler, Gertrud .
PHARMACOLOGY, 2009, 83 (04) :217-222
[4]   Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors [J].
Alves Jesus, Carlos Henrique ;
Bello Redivo, Daiany Darlly ;
Gasparin, Alexia Thamara ;
Sotomaior, Bruna Bittencourt ;
de Carvalho, Milene Cristina ;
Genaro, Karina ;
Zuardi, Antonio Waldo ;
Cecilio Hallak, Jaime Eduardo ;
Crippa, Jose Alexandre ;
Zanoveli, Janaina Menezes ;
da Cunha, Joice Maria .
BRAIN RESEARCH, 2019, 1715 :156-164
[5]   The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors [J].
Bakas, T. ;
van Nieuwenhuijzen, P. S. ;
Devenish, S. O. ;
McGregor, I. S. ;
Arnold, J. C. ;
Chebib, M. .
PHARMACOLOGICAL RESEARCH, 2017, 119 :358-370
[6]   Computational systems pharmacology analysis of cannabidiol: a combination of chemogenomics-knowledgebase network analysis and integrated in silico modeling and simulation [J].
Bian, Yue-min ;
He, Xi-bing ;
Jing, Yan-kang ;
Wang, Li-rong ;
Wang, Jun-mei ;
Xie, Xiang-Qun .
ACTA PHARMACOLOGICA SINICA, 2019, 40 (03) :374-386
[7]   Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide [J].
Bisogno, T ;
Hanus, L ;
De Petrocellis, L ;
Tchilibon, S ;
Ponde, DE ;
Brandi, I ;
Moriello, AS ;
Davis, JB ;
Mechoulam, R ;
Di Marzo, V .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) :845-852
[8]   Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis [J].
Blake, DR ;
Robson, P ;
Ho, M ;
Jubb, RW ;
McCabe, CS .
RHEUMATOLOGY, 2006, 45 (01) :50-52
[9]   Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain [J].
Britch, Stevie C. ;
Goodman, Alan G. ;
Wiley, Jenny L. ;
Pondelick, Abby M. ;
Craft, Rebecca M. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2020, 373 (03) :416-428
[10]   Cannabidiol-Δ9-tetrahydrocannabinol interactions on acute pain and locomotor activity [J].
Britch, Stevie C. ;
Wiley, Jenny L. ;
Yu, Zhihao ;
Clowers, Brian H. ;
Craft, Rebecca M. .
DRUG AND ALCOHOL DEPENDENCE, 2017, 175 :187-197